Pioglitazone diabetes drug

Pioglitazone diabetes drug

C009/7217 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 2.1MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Pioglitazone diabetes drug. Pioglitazone, which is marketed under the name Actos, belongs to a group of drugs known as thiazolidinediones that are used to treat type II diabetes. Pioglitazone controls blood sugar levels by reducing the production and secretion of glucose by the liver and increasing the body's sensitivity to insulin, the hormone that regulates blood glucose levels. It requires that some insulin is produced by the pancreas and so cannot be used to treat type I diabetes.

Release details: Model release not required. Property release not available.

Keywords: 1, 30mg, actos, antihyperglycaemic agent, antihyperglycemic agent, biochemical, biochemistry, blood glucose level, blood glucose regulation, blood sugar level, box, boxed, cardiac, chemical, chemistry, close-up, compound, compounds, detail, diabetes, diabetic, drug, hydrochloride, insulin sensitiser, medical, medicine, one, packaged, packaging, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pioglitazone, prescription, regulator, single, tablets, takeda pharmaceuticals, thiazolidinedione, type 2, type ii

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.